Detection of human P-glycoprotein-like molecule in azole-resistant Candida albicans from HIV+ patients

Microbial Drug Resistance

Volumn 8, Issue 3, 2002, Pages 235-244

  Stringaro, Annarita ^a   Molinari, Agnese ^a   Calcabrini, Annarica ^a   Arancia, Giuseppe ^a   Ceddia, Pier Giuseppe ^a   Cianfriglia, Maurizio ^a   Poloni, Francesca ^a   Mondello, Francesca ^a   Angiolella, Letizia ^b   De Bernardis, Flavia ^a   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYCLOSPORIN A; FLUCONAZOLE; GLYCOPROTEIN P; ITRACONAZOLE; MONOCLONAL ANTIBODY; PYRROLE; VERAPAMIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC RESISTANCE; ANTIBODY LABELING; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CANDIDA ALBICANS; CONTROLLED STUDY; FLOW CYTOMETRY; FUNGUS; GENETIC CODE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE HOMOLOGY;

ANTIBODIES, MONOCLONAL; ANTIFUNGAL AGENTS; AZOLES; CANDIDA ALBICANS; DOXORUBICIN; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; P-GLYCOPROTEIN;

BACTERIA (MICROORGANISMS); CANDIDA; CANDIDA ALBICANS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036738426     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/107662902760326968     Document Type: Article

References (41)

1. Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance
2. Microdilution antifungal susceptibility testing of Candida albicans and Cryptococcus neoformans with and without agitation: An eight-centre collaborative study
3. Intracellular P-glycoprotein in multidrug resistant tumor cells
4. Characterization by somatic cell genetics of a monoclonal antibody to the MDR1 gene product (P-glycoprotein): Determination of P-glycoprotein expression in multi-drug resistant KB and CEM cell variants
5. P-glycoprotein mapping. Identification of a linear human specific epitope in the fourth loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multi-drug resistance cells
6. Oropharyngeal candidiasis resistance to fluconazole in patients infected by HIV
7. Pharmacology of drugs that alter multidrug resistance in cancer
8. Membrane transporters and antifungal drug resistance
9. Reversal of daunorubicin resistance in P388/ADR cells by itraconazole
10. ABC transporters from microorganisms to man
11. The lipid composition of azole-sensitive and azole-resistant strains of Candida albicans
12. Azole drug resistance in yeasts
13. P-glycoprotein: Multidrug resistance and a superfamily of membrane-associated transport proteins
14. Update on antifungal resistance
15. Antimicrobial susceptibility testing
16. Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro
17. Interaction of cyclosporin and itraconazole
18. Reduced intracellular accumulation of azole antifungal results in resistance in Candida albicans isolate NCPF 3363
19. High prevalence of antifungal resistance in Candida spp. From patients with AIDS
20. Molecular analysis of cyp51 from fluconazole-resistant Candida albicans strains
21. Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans
22. P-glycoprotein-mediated transport of itraconazole across the blood-brain barrier
23. Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells
24. Resistance of yeast to azole-derivate antifungals
25. Epidemiology of Candida infection in AIDS
26. Mechanism of fluconazole resistance in Candida krusei
27. Microbial multi-drug resistance ABC transporters
28. A new immunohistochemical methodology for the specific detection of MDR 1-P-glycoprotein in human tissue based on phage-displayed peptides mimicking the MMM4.17 epitope
29. Selection of phage-displayed peptides mimicking an extracellular epitope of human MDRI-P-glycoprotein
30. Resistance of Candida species to fluconazole
31. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans
32. Activity of fluconazole (UK 49, 858) and ketoconazole against Candida albicans in vitro and in vivo
33. Azole resistance in Candida albicans
34. Mechanism of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters
35. Functional intracellular P-glycoprotein
36. Mutation in cytochrome P450-dependent 14α-demethylase results in decreased affinity of azole antifungals
37. Molecular mechanisms of drug resistance in fungi
38. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug
39. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: Implications for antifungal azole resistance
40. Clinical, cellular and molecular factor that contribute to antifungal drug resistance